NISA INVESTMENT ADVISORS, LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 247 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.6%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q2 2022$67,000
+28.8%
2,110
+39.7%
0.00%
Q1 2022$52,000
+108.0%
1,510
+75.6%
0.00%
Q4 2021$25,000
+13.6%
8600.0%0.00%
Q3 2021$22,000
-71.4%
860
-61.1%
0.00%
Q2 2021$77,000
-58.6%
2,210
-51.6%
0.00%
-100.0%
Q1 2021$186,000
+24.0%
4,570
+31.7%
0.00%0.0%
Q4 2020$150,000
-40.5%
3,470
-24.1%
0.00%
-50.0%
Q3 2020$252,000
+15.1%
4,570
+31.7%
0.00%0.0%
Q2 2020$219,000
-27.0%
3,470
-40.9%
0.00%
-33.3%
Q1 2020$300,000
-37.2%
5,875
-2.3%
0.00%
-25.0%
Q4 2019$478,000
-7.7%
6,015
-43.7%
0.00%
-20.0%
Q3 2019$518,000
+15.4%
10,675
+24.9%
0.01%
+25.0%
Q2 2019$449,000
-0.7%
8,5450.0%0.00%0.0%
Q1 2019$452,000
+28.8%
8,5450.0%0.00%0.0%
Q4 2018$351,000
+76.4%
8,545
+62.9%
0.00%
+100.0%
Q3 2018$199,000
-15.0%
5,245
+1.4%
0.00%0.0%
Q2 2018$234,000
-22.5%
5,1750.0%0.00%
-33.3%
Q1 2018$302,000
+43.1%
5,175
-3.3%
0.00%
+50.0%
Q4 2017$211,000
+27.1%
5,3500.0%0.00%0.0%
Q3 2017$166,000
+14.5%
5,3500.0%0.00%0.0%
Q2 2017$145,000
-67.0%
5,350
-55.1%
0.00%
-60.0%
Q1 2017$439,000
+7216.7%
11,910
+2877.5%
0.01%
Q4 2016$6,0004000.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2022
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 356,270$24,262,00023.36%
Twin Securities, Inc. 376,669$25,651,00011.94%
Paradigm Biocapital Advisors LP 1,175,879$80,077,00010.68%
Chicago Capital Management, LLC 246,246$16,769,0009.12%
HARVEST MANAGEMENT LLC 141,500$9,636,0007.78%
Fernwood Investment Management, LLC 174,724$11,899,0005.02%
ArchPoint Investors 168,725$11,490,0004.69%
HAVENS ADVISORS LLC 46,000$3,133,0004.69%
Perceptive Advisors 2,322,247$158,145,0004.59%
Crabel Capital Management, LLC 112,680$7,674,0004.48%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders